Skip to main navigation Skip to search Skip to main content

High definition immunologic profiling following open label adminisration of a tetravaletn dengue vaccine to people in Thailand with different baseline flavivirus immuni status

Project: Research

Project Details

StatusActive
Effective start/end date04/14/2304/13/27

Funding

  • Merck Sharp and Dohme Limited Liability Corporation: $202,743.55